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1. Introduction {#efs24671-sec-0002}
===============

1.1. Background and Terms of Reference {#efs24671-sec-0003}
--------------------------------------

Regulation (EC) No 1831/2003[1](#efs24671-note-1005){ref-type="fn"} establishes the rules governing the Community authorisation of additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in accordance with Article 7 and in addition, Article 10(2) of that Regulation also specifies that for existing products within the meaning of Article 10(1), an application shall be submitted in accordance with Article 7, within a maximum of 7 years after the entry into force of this Regulation.

The European Commission received a request from Feed Flavourings Authorisation Consortium European Economic Interest Grouping (FFAC EEIG)[2](#efs24671-note-1006){ref-type="fn"} for authorisation of 22 substances belonging to chemical group (CG) 24 (2,3‐diethylpyrazine, 2‐ethyl‐3‐methylpyrazine, 5,6,7,8‐tetrahydroquinoxaline, 2,3,5,6‐tetramethylpyrazine, 2,3,5‐trimethylpyrazine, 2,5‐dimethylpyrazine, 2,6‐dimethylpyrazine, 2‐ethylpyrazine, 2‐ethyl‐3,5‐dimethylpyrazine, 2,5 or 6‐methoxy‐3‐methylpyrazine, 2‐methylpyrazine, 5‐methylquinoxaline, acetylpyrazine, 5H‐5‐methyl‐6,7‐dihydrocyclopenta(b)pyrazine (herein referred to as 6,7‐dihydro‐5‐methyl‐5H‐cyclopenta(b)pyrazine), 2‐isobutyl‐3‐methoxypyrazine, 2‐acetyl‐3‐ethylpyrazine, 2,3‐dimethylpyrazine, diethyl‐5‐methylpyrazine (herein referred to as 2,3‐diethyl‐5‐methylpyrazine), 2‐(sec‐butyl)‐3‐methoxypyrazine, 2‐ethyl‐3,(5or6)dimethylpyrazine (herein referred to as 3,(5 or 6)‐2‐ethyl‐dimethylpyrazine), 2‐ethyl‐3‐methoxypyrazine, 2‐methoxy‐3‐methylpyrazine), when used as feed additives for all animal species (category: sensory additives; functional group: flavourings). CG 24 for flavouring substances is defined in Commission Regulation (EC) No 1565/2000[3](#efs24671-note-1007){ref-type="fn"} as 'Pyrazine derivatives'.

According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re‐evaluation of an authorised feed additive). During the course of the assessment, the applicant withdrew the application for the use of chemically defined flavourings in water for drinking.[4](#efs24671-note-1008){ref-type="fn"} EFSA received directly from the applicant the technical dossier in support of this application. The particulars and documents in support of the application were considered valid by EFSA as of 10 September 2010.

According to Article 8 of Regulation (EC) No 1831/2003, EFSA after verifying the particulars and documents submitted by the applicant shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment, and on the efficacy of 2,3‐diethylpyrazine \[The EU Flavour Information System (FLAVIS) Number 14.005\], 2‐ethyl‐3‐methylpyrazine \[14.006\], 5,6,7,8‐tetrahydroquinoxaline \[14.015\], 2,3,5,6‐tetramethylpyrazine \[14.018\], 2,3,5‐trimethylpyrazine \[14.019\], 2,5‐dimethylpyrazine \[14.020\], 2,6‐dimethylpyrazine \[14.021\], 2‐ethylpyrazine \[14.022\], 2‐ethyl‐3,5‐dimethylpyrazine \[14.024\], 2,5 or 6‐methoxy‐3‐methylpyrazine \[14.025\], 2‐methylpyrazine \[14.027\], 5‐methylquinoxaline \[14.028\], acetylpyrazine \[14.032\], 6,7‐dihydro‐5‐methyl‐5H‐cyclopenta(b)pyrazine \[14.037\], 2‐isobutyl‐3‐methoxypyrazine \[14.043\], 2‐acetyl‐3‐ethylpyrazine \[14.049\], 2,3‐dimethylpyrazine \[14.050\], 2,3‐diethyl‐5‐methylpyrazine \[14.056\], 2‐(sec‐butyl)‐3‐methoxypyrazine \[14.062\], 3,(5‐ or 6‐)‐dimethyl‐2‐ethylpyrazine \[14.100\], 2‐ethyl‐3‐methoxypyrazine \[14.112\], 2‐methoxy‐3‐methylpyrazine \[14.126\] when used under the proposed conditions of use (see Section [3.1.3](#efs24671-sec-0012){ref-type="sec"}).

1.2. Additional information {#efs24671-sec-0004}
---------------------------

All 22 substances except 2‐ethyl‐3‐methoxypyrazine \[14.112\] and 2‐methoxy‐3‐methylpyrazine \[14.126\] have been assessed by the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives (JECFA; WHO, [2002a](#efs24671-bib-0033){ref-type="ref"},[b](#efs24671-bib-0034){ref-type="ref"}) and were considered safe for use in food. No acceptable daily intake (ADI) values were established.

Subsequently, the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) assessed all compounds and concluded that they do not give rise to safety concerns when used as flavour in food (EFSA [2008a](#efs24671-bib-0006){ref-type="ref"}, EFSA CEF Panel, [2011a](#efs24671-bib-0008){ref-type="ref"}).

All 22 compounds are all currently listed in the European Union (EU) database of flavouring substances[5](#efs24671-note-1009){ref-type="fn"} and in the EU Register of Feed Additives, and thus authorised for use in food and feed in the EU. They have not been previously assessed by EFSA as feed additives.

Regulation (EC) No 429/2008[6](#efs24671-note-1010){ref-type="fn"} allows substances already approved for use in human food to be assessed with a more limited procedure than for other feed additives. However, the use of this procedure is always subject to the condition that food safety assessment is relevant to the use in feed.

2. Data and methodologies {#efs24671-sec-0005}
=========================

2.1. Data {#efs24671-sec-0006}
---------

The present assessment is based on data submitted by the applicant in the form of a technical dossier[7](#efs24671-note-1011){ref-type="fn"} in support of the authorisation request for the use of the compounds belonging to CG 24 as feed additives. The technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003, Regulation (EC) No 429/2008 and the applicable EFSA guidance documents.

The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) has sought to use the data provided by the applicant together with data from other sources, such as previous risk assessments by EFSA or other expert bodies, peer‐reviewed scientific papers and experts\' knowledge, to deliver the present output.

EFSA has verified the European Union Reference Laboratory (EURL) report as it relates to the methods used for the control of flavourings of the 'pyrazine derivatives' in animal feed. The Executive Summary of the EURL report can be found in Annex [A](#efs24671-sec-0026){ref-type="sec"}.[8](#efs24671-note-1012){ref-type="fn"}

2.2. Methodologies {#efs24671-sec-0007}
------------------

The approach followed by the FEEDAP Panel to assess the safety and the efficacy of pyrazine derivatives is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance documents: Guidance for the preparation of dossiers for sensory additives (EFSA FEEDAP Panel, [2012a](#efs24671-bib-0010){ref-type="ref"}), Technical Guidance for assessing the safety of feed additives for the environment (EFSA, [2008b](#efs24671-bib-0007){ref-type="ref"}), Guidance for the preparation of dossiers for additives already authorised for use in food (EFSA FEEDAP Panel, [2012b](#efs24671-bib-0011){ref-type="ref"}), Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, [2012c](#efs24671-bib-0012){ref-type="ref"}) and Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, [2012d](#efs24671-bib-0013){ref-type="ref"}).

3. Assessment {#efs24671-sec-0008}
=============

3.1. Characterisation {#efs24671-sec-0009}
---------------------

### 3.1.1. Characterisation of the flavouring additives {#efs24671-sec-0010}

The molecular structures of the 22 additives under application are shown in Figure [1](#efs24671-fig-0001){ref-type="fig"} and their physicochemical characteristics in Table [1](#efs24671-tbl-0001){ref-type="table"}.

![Molecular structures and \[FLAVIS numbers\] of the 22 flavouring compounds under assessment\
(a): In the technical dossier, the compound is identified as 5*H*‐5‐methyl‐6,7‐dihydrocyclopenta(b)pyrazine.(b): In the technical dossier, the compound is identified as diethyl‐5‐methylpyrazine.(c): In the technical dossier, the compound is identified as 2‐ethyl‐3,(5 or 6)dimethylpyrazine.](EFS2-15-e04671-g001){#efs24671-fig-0001}

###### 

Chemical Abstracts Service (CAS) and FLAVIS numbers and some characteristics of the 22 flavouring compounds under assessment

  EU Register name                                                               CAS No                                              FLAVIS No   Molecular formula   Molecular weight   Physical state   Log *K* ~ow~ [a](#efs24671-note-0006){ref-type="fn"}
  ------------------------------------------------------------------------------ --------------------------------------------------- ----------- ------------------- ------------------ ---------------- ------------------------------------------------------
  2,3‐Diethylpyrazine                                                            15707‐24‐1                                          14.005      C~8~H~12~N~2~       136.2              Liquid           1.51
  2‐Ethyl‐3‐methylpyrazine                                                       15707‐23‐0                                          14.006      C~7~H~10~N~2~       122.17             Liquid           1.07
  5,6,7,8‐Tetrahydroquinoxaline                                                  34413‐35‐9                                          14.015      C~8~H~10~N~2~       134.18             Solid            1.41
  2,3,5,6‐Tetramethylpyrazine                                                    1124‐11‐4                                           14.018      C~8~H~12~N~2~       136.2              Solid            1.82
  2,3,5‐Trimethylpyrazine                                                        14667‐55‐1                                          14.019      C~7~H~10~N~2~       122.17             Liquid           0.95
  2,5‐Dimethylpyrazine                                                           123‐32‐0                                            14.020      C~6~H~8~N~2~        108.14             Liquid           0.63
  2,6‐Dimethylpyrazine                                                           108‐50‐9                                            14.021      C~6~H~8~N~2~        108.14             Solid            0.54
  2‐Ethylpyrazine                                                                13925‐00‐3                                          14.022      C~6~H~8~N~2~        108.14             Liquid           0.69
  2‐Ethyl‐3,5‐dimethylpyrazine                                                   13925‐07‐0[b](#efs24671-note-0007){ref-type="fn"}   14.024      C~8~H~12~N~2~       136.2              Liquid           1.63
  2,5‐ or 6‐Methoxy‐3‐methylpyrazine[c](#efs24671-note-0008){ref-type="fn"}      63450‐30‐6                                          14.025      C~6~H~8~ON~2~       124.14             Liquid           −0.28
  2‐Methylpyrazine                                                               109‐08‐0                                            14.027      C~5~H~6~N~2~        94.12              Liquid           0.21
  5‐Methylquinoxaline                                                            13708‐12‐8                                          14.028      C~9~H~8~N~2~        144.18             Liquid           2.04
  Acetylpyrazine                                                                 22047‐25‐2                                          14.032      C~6~H~6~ON~2~       122.13             Solid            0.2
  6,7‐Dihydro‐5‐methyl‐5*H*‐cyclopenta(b)pyrazine                                23747‐48‐0                                          14.037      C~8~H~10~N~2~       134.18             Liquid           1.83
  2‐Isobutyl‐3‐methoxypyrazine                                                   24683‐00‐9                                          14.043      C~9~H~14~ON~2~      166.22             Liquid           2.86
  2‐Acetyl‐3‐ethylpyrazine                                                       32974‐92‐8                                          14.049      C~8~H~10~ON~2~      150.18             Liquid           1.15
  2,3‐Dimethylpyrazine                                                           5910‐89‐4                                           14.050      C~6~H~8~N~2~        108.14             Liquid           0.54
  2,3‐Diethyl‐5‐methylpyrazine                                                   18138‐04‐0                                          14.056      C~9~H~14~N~2~       150.22             Liquid           1.95
  2‐(*sec*‐Butyl)‐3‐methoxypyrazine                                              24168‐70‐5                                          14.062      C~9~H~14~ON~2~      166.22             Liquid           1.92
  3,(5‐ or 6‐)‐Dimethyl‐2‐ethylpyrazine[d](#efs24671-note-0009){ref-type="fn"}   27043‐05‐6                                          14.100      C~8~H~12~N~2~       136.2              Liquid           2.07[e](#efs24671-note-0010){ref-type="fn"}
  2‐Ethyl‐3‐methoxypyrazine                                                      25680‐58‐4                                          14.112      C~7~H~10~N~2~O      132.14             Liquid           1.80
  2‐Methoxy‐3‐methylpyrazine                                                     2847‐30‐5                                           14.126      C~6~H~8~N~2~O       124.14             Liquid           1.24

EU: European Union; CAS No: Chemical Abstract Service number.; FLAVIS number: EU Flavour Information System number.

Logarithm of octanol--water partition coefficient.

Three CAS numbers have been used to identify 2‐ethyldimethylpyrazine, two refer to 2‐ethyl‐3,5‐dimethylpyrazine (CAS Nos 13925‐07‐0 and 55031‐15‐7) and one to mixture of isomers 2‐ethyl‐3,(5 or 6)‐dimethylpyrazine (CAS No 27043‐05‐6). They are all relevant to the assessment of this compound.

Mixture of three positional methoxy‐isomers: 2‐methoxy‐3‐methylpyrazine (75--85%); 2‐methoxy‐5‐methylpyrazine (15--25%) and 2‐methoxy‐6‐methylpyrazine (1--2%) (sum 97%). The CAS number applies to all three isomers. Different CAS numbers are associated to individual isomers: 2‐methoxy‐3‐methylpyrazine (CAS No 2847‐30‐5), 2‐methoxy‐5‐methylpyrazine (CAS No 2882‐22‐6) and 5‐methoxy‐3‐methylpyrazine (CAS No 2882‐21‐5).

The additive is a mixture of the two isomers. The CAS number applies to the mixture. A different CAS number (55031‐15‐7) reported in the dossier refers to 2‐ethyl‐3,5‐dimethylpyrazine. See also (2).

Generated from Epi‐Suite 4.01.

John Wiley & Sons, Ltd

These substances are produced by chemical synthesis. Several routes of synthesis are available and described in the dossier.[9](#efs24671-note-1013){ref-type="fn"}

Batch‐to‐batch variation data were provided for five batches of each additive with the exception of 2,3‐diethylpyrazine (one batch available due to the low use volume), 2‐ethylpyrazine and 2‐acetyl‐3‐ethylpyrazine (three batches), diethyl‐5‐methyl pyrazine and 2‐(*sec*‐butyl)‐3‐methoxypyrazine (four batches).[10](#efs24671-note-1014){ref-type="fn"} The content of the active substance for all compounds exceeded the JECFA specifications (Table [2](#efs24671-tbl-0002){ref-type="table"}).

###### 

Identity of the substances and data on purity

  EU Register name                                  FLAVIS No   JECFA specification minimum %[a](#efs24671-note-0012){ref-type="fn"}   Assay %                                       
  ------------------------------------------------- ----------- ---------------------------------------------------------------------- --------------------------------------------- ------------
  2,3‐Diethylpyrazine                               14.005      \> 97                                                                  99.2[b](#efs24671-note-0013){ref-type="fn"}   --
  2‐Ethyl‐3‐methylpyrazine                          14.006      \> 97[d](#efs24671-note-0015){ref-type="fn"}                           99.9                                          99.5--100
  5,6,7,8‐Tetrahydroquinoxaline                     14.015      \> 98                                                                  99.3                                          99.0--99.7
  2,3,5,6‐Tetramethylpyrazine                       14.018      \> 95                                                                  99.7                                          98.5--100
  2,3,5‐Trimethylpyrazine                           14.019      \> 98                                                                  99.6                                          98.2--100
  2,5‐Dimethylpyrazine                              14.020      \> 98[d](#efs24671-note-0015){ref-type="fn"}                           99.6                                          99.2--99.9
  2,6‐Dimethylpyrazine                              14.021      \> 98[d](#efs24671-note-0015){ref-type="fn"}                           99.7                                          99.4--100
  2‐Ethylpyrazine                                   14.022      \> 98                                                                  99.4                                          99.3--99.6
  2‐Ethyl‐3,5‐dimethylpyrazine                      14.024      \> 95                                                                  99.9                                          99.6--100
  2,5 or 6‐Methoxy‐3‐methylpyrazine                 14.025      \> 97[d](#efs24671-note-0015){ref-type="fn"}                           100.0                                         99.9--100
  2‐Methylpyrazine                                  14.027      \> 98                                                                  99.8                                          99.6--100
  5‐Methylquinoxaline                               14.028      \> 98                                                                  100.0                                         99.9--100
  Acetylpyrazine                                    14.032      \> 99                                                                  99.9                                          99.8--100
  6,7‐Dihydro‐5‐methyl‐5*H*‐cyclopenta(b)pyrazine   14.037      \> 97                                                                  98.4                                          98.3--98.8
  2‐Isobutyl‐3‐methoxypyrazine                      14.043      \> 95                                                                  99.8                                          99.6--100
  2‐Acetyl‐3‐ethylpyrazine                          14.049      \> 98                                                                  99.8                                          99.6--100
  2,3‐Dimethylpyrazine                              14.050      \> 95[d](#efs24671-note-0015){ref-type="fn"}                           99.8                                          99.6--100
  2,3‐Diethyl‐5‐methylpyrazine                      14.056      \> 98                                                                  99.6                                          99.4--99.6
  2‐(*sec*‐Butyl)‐3‐methoxypyrazine                 14.062      \> 99                                                                  99.6                                          99.0--100
  3,(5‐ or 6‐)‐Dimethyl‐2‐ethylpyrazine             14.100      \> 95                                                                  99.9[d](#efs24671-note-0015){ref-type="fn"}   99.9--100
  2‐Ethyl‐3‐methoxypyrazine                         14.112      \> 99                                                                  99.8                                          99.5--99.9
  2‐Methoxy‐3‐methylpyrazine                        14.126      \> 97                                                                  99.3[c](#efs24671-note-0014){ref-type="fn"}   97.4--100

FLAVIS number: EU Flavour Information System number.

FAO, [2006](#efs24671-bib-0014){ref-type="ref"}.

One batch, use of the product 1 kg/year or less.

Specifications reflect commercial product.

Sum of isomers.

John Wiley & Sons, Ltd

Potential contaminants are considered as part of the product specification and are monitored as part of the Hazard Analysis and Critical Control Point procedure applied by all consortium members. The parameters considered include residual solvents, heavy metals and other undesirable substances. However, no evidence of compliance was provided for these parameters.

### 3.1.2. Stability {#efs24671-sec-0011}

The shelf‐life for the compounds under assessment is at least 24 months when stored in closed containers under recommended conditions. This assessment is made on the basis of compliance with the original specification over this storage period.

### 3.1.3. Conditions of use {#efs24671-sec-0012}

The applicant proposes the use of all of the 22 additives in feed for all animal species without withdrawal. For all 22 additives, the applicant proposes a normal use level of 0.1 mg/kg feed and a high use level of 0.5 mg/kg.

3.2. Safety {#efs24671-sec-0013}
-----------

The assessment of safety is based on the highest use level proposed by the applicant (0.5 mg/kg complete feed).

### 3.2.1. Absorption, distribution, metabolism and excretion (ADME) {#efs24671-sec-0014}

Compounds belonging to CG 24 are absorbed from the gastrointestinal tract and share common pathways of metabolism: (i) oxidation of the side‐chain(s) of alkyl‐, alicyclic‐ and alkylaryl substituted pyrazine derivatives, (ii) oxidation of methylpyrazines to the corresponding pyrazine‐2‐carboxylic acids (iii) hydroxylation of the pyrazine ring, (iv) reduction of the ketone functional group of acylated pyrazines to the corresponding secondary alcohol and (v) conjugation of products of oxidative metabolism with glycine, glucuronic acid or sulfate, and glucuronidation of secondary alcohols (WHO, [2002a](#efs24671-bib-0033){ref-type="ref"},[b](#efs24671-bib-0034){ref-type="ref"}, FAS 48).

Metabolic studies of pyrazine derivatives mainly performed in the rat after oral administration showed that rats dosed individually with a number of compounds under assessment have an efficient excretion mechanism for pyrazine derivatives at 100 mg/kg body weight (bw). About 90% of 2‐methylpyrazine, 2,5‐dimethylpyrazine and 2,6‐dimethylpyrazine were excreted within 24 h as the corresponding pyrazine‐2‐carboxylic acid derivative. This acid was mainly eliminated unconjugated, with 10--15% excreted as a glycine conjugate. For 2,3‐dimethylpyrazine, due to the steric hindrance of the methyl groups, only 10--15% was oxidised to 2‐methylpyrazine‐3‐carboxylic acid. 2,3‐Dimethyl‐5‐hydroxypyrazine is the main metabolite, attaining about 40% of the administered dose and eliminated as a conjugate. Also in rats, 2‐isobutyl‐3‐methoxypyrazine was eliminated in urine mainly as the conjugate of the O‐demethylated metabolite. A minor metabolite 2‐methoxy‐3‐(2‐carboxypropyl)pyrazine was also identified resulting from the oxidation of the aliphatic side‐chain (Hawksworth and Scheline, [1975](#efs24671-bib-0020){ref-type="ref"}).

Studies of metabolism of pyrazine derivatives in animals other than rodents are lacking in the scientific literature. However, the enzymes involved in the biotransformation pathways of these compounds are present in all target species. Alkyl groups of pyrazine derivatives are oxidised mainly by P450 type enzymes to form the corresponding alcohols or carboxylic acids; the ring is hydroxylated by molybdenum‐containing oxidases of the xanthine oxidase type (Müller and Rappert, [2010](#efs24671-bib-0025){ref-type="ref"}). The CYP450 monooxygenase families are present and have been characterised in a number of food‐producing animals, including ruminants, horses, pigs, (Nebbia et al., [2003](#efs24671-bib-0026){ref-type="ref"}; Ioannides, [2006](#efs24671-bib-0021){ref-type="ref"}; Fink‐Gremmels, [2008](#efs24671-bib-0016){ref-type="ref"}), fish (Wolf and Wolfe, [2005](#efs24671-bib-0035){ref-type="ref"}) and birds (Blevins et al., [2012](#efs24671-bib-0002){ref-type="ref"}). The molybdenum hydroxylases are also present in several animal species (Morikawa et al., [1997](#efs24671-bib-0024){ref-type="ref"}; Hainline and Rajagopalan, [2013](#efs24671-bib-0019){ref-type="ref"}). Cytosolic carbonyl reductases that reduce ketones to secondary alcohols were characterised in the liver and kidney of several animal species, namely chicken, rabbit and sheep, as reviewed by Felsted and Bachur ([1980](#efs24671-bib-0015){ref-type="ref"}). Thus, it is expected that the acyl‐pyrazine derivatives can be reduced and subsequently conjugated for excretion. Phase II conjugation via glucuronidation, sulfation or addition of glycine has been reported to occur in mammals although the predominance of one pathway over another varies among animal species (Gupta, [2007](#efs24671-bib-0017){ref-type="ref"}). All target species, also carry out conjugation reactions with sulfate and glucuronic acid (Watkins and Klaassen, [1986](#efs24671-bib-0031){ref-type="ref"}; James, [1987](#efs24671-bib-0022){ref-type="ref"}; Gusson et al., [2006](#efs24671-bib-0018){ref-type="ref"}), producing water‐soluble derivatives that are eliminated in urine. The FEEDAP Panel notes that for feline species the capacity for conjugation is limited (Court, [2013](#efs24671-bib-0003){ref-type="ref"}).

### 3.2.2. Toxicological studies {#efs24671-sec-0015}

Subchronic, repeated‐dose studies, with multiple doses tested could not be found for any of the compounds under assessment.

Summaries of toxicological data on single dose level studies are available for 2,3‐diethylpyrazine \[14.005\], 2‐ethyl‐3‐methylpyrazine \[14.006\], 2‐ethyl‐3,5‐dimethylpyrazine \[14.024\], 2,5 or 6‐methoxy‐3‐methylpyrazine \[14.025\] and 5‐methylquinoxaline \[14.028\] (Posternak et al., [1969](#efs24671-bib-0027){ref-type="ref"}), and acetylpyrazine \[14.032\] (Posternak et al., [1975](#efs24671-bib-0028){ref-type="ref"}). Secondary references referred to repeated dose toxicity studies (90 days, one dose tested) in rat performed with 5,6,7,8‐tetrahydroquinoxaline \[14.015\] (Oser, 1970), 2,3,5,6‐tetramethylpyrazine \[14.018\] (Oser, 1969a), 2,3,5‐trimethylpyrazine \[14.019\] (Oser, 1969b), 2,6‐dimethylpyrazine \[14.021\], (Oser, 1969d), 3,(5‐ or 6‐)‐dimethyl‐2‐ethylpyrazine \[14.100\] (Oser, 1969c) and 6,7‐dihydro‐5‐methyl‐5*H*‐cyclopenta(b)pyrazine \[14.037\] (Wheldon and Krajkeman, [1967](#efs24671-bib-0032){ref-type="ref"}). Study reports for these compounds are not available and the FEEDAP Panel is unable to confirm the no observed adverse effect levels (NOAELs) derived.

### 3.2.3. Safety for the target species {#efs24671-sec-0016}

The first approach to the safety assessment for target species takes account of the applied use levels in animal feed relative to the maximum reported exposure of humans on the basis of the metabolic body weight. The data for human exposure in the EU (EFSA CEF Panel, [2011a](#efs24671-bib-0008){ref-type="ref"},[b](#efs24671-bib-0009){ref-type="ref"}) ranges from 0.1 to 100 μg/person per day, corresponding to 0.005 to 4.6 μg/kg^0.75^ per day. Table [3](#efs24671-tbl-0003){ref-type="table"} summarises the result of the comparison with human exposure for representative target animals. The body weight of target animals is taken from the default values shown in Table [4](#efs24671-tbl-0004){ref-type="table"}.

###### 

Comparison of exposure of humans and target animals to the flavourings under application

  EU Register name                                  Use level in feed (mg/kg)   Human exposure (μg/kg bw^0.75^ per day)[a](#efs24671-note-0017){ref-type="fn"}   Target animal exposure (μg/kg bw^0.75^ per day)          
  ------------------------------------------------- --------------------------- -------------------------------------------------------------------------------- ------------------------------------------------- ------ ------
  2,3‐Diethylpyrazine                               0.5                         0.07                                                                             11.8                                              52.6   77.7
  2‐Ethyl‐3‐methylpyrazine                          0.5                         3.34                                                                             11.8                                              52.6   77.7
  5,6,7,8‐Tetrahydroquinoxaline                     0.5                         0.37                                                                             11.8                                              52.6   77.7
  2,3,5,6‐Tetramethylpyrazine                       0.5                         0.31                                                                             11.8                                              52.6   77.7
  2,3,5‐Trimethylpyrazine                           0.5                         4.46                                                                             11.8                                              52.6   77.7
  2,5‐Dimethylpyrazine                              0.5                         0.88                                                                             11.8                                              52.6   77.7
  2,6‐Dimethylpyrazine                              0.5                         0.06                                                                             11.8                                              52.6   77.7
  2‐Ethylpyrazine                                   0.5                         0.10                                                                             11.8                                              52.6   77.7
  2‐Ethyl‐3,5‐dimethylpyrazine                      0.5                         0.06                                                                             11.8                                              52.6   77.7
  2,5 or 6‐Methoxy‐3‐methylpyrazine                 0.5                         0.70[b](#efs24671-note-0018){ref-type="fn"}                                      11.8                                              52.6   77.7
  2‐Methylpyrazine                                  0.5                         0.79                                                                             11.8                                              52.6   77.7
  5‐Methylquinoxaline                               0.5                         1.02                                                                             11.8                                              52.6   77.7
  Acetylpyrazine                                    0.5                         0.56                                                                             11.8                                              52.6   77.7
  6,7‐Dihydro‐5‐methyl‐5*H*‐cyclopenta(b)pyrazine   0.5                         0.18                                                                             11.8                                              52.6   77.7
  2‐Isobutyl‐3‐methoxypyrazine                      0.5                         4.92                                                                             11.8                                              52.6   77.7
  2‐Acetyl‐3‐ethylpyrazine                          0.5                         0.03                                                                             11.8                                              52.6   77.7
  2,3‐Dimethylpyrazine                              0.5                         0.65                                                                             11.8                                              52.6   77.7
  Diethyl‐5‐methylpyrazine                          0.5                         0.05                                                                             11.8                                              52.6   77.7
  2‐(*sec*‐Butyl)‐3‐methoxypyrazine                 0.5                         0.04                                                                             11.8                                              52.6   77.7
  3,(5‐ or 6‐)‐Dimethyl‐2‐ethylpyrazine             0.5                         1.76                                                                             11.8                                              52.6   77.7
  2‐Ethyl‐3‐methoxypyrazine                         0.5                         0.05[b](#efs24671-note-0018){ref-type="fn"}                                      11.8                                              52.6   77.7
  2‐Methoxy‐3‐methylpyrazine                        0.5                         0.70                                                                             11.8                                              52.6   77.7

bw: body weight.

Metabolic body weight (kg bw^0.75^) for a 60‐kg person = 21.6.

EU figures not available (exposure based on US intake figures).

John Wiley & Sons, Ltd

Table [3](#efs24671-tbl-0003){ref-type="table"} shows that for all compounds the intake by the target animals exceeds that of humans resulting from use in food. As a consequence, safety for the target species at the feed concentration applied cannot be derived from the risk assessment for food use.

As an alternative, the maximum feed concentration considered as safe for the target animal can be derived from the lowest NOAEL available. However, adequate subchronic, repeated‐dose studies performed with the additives under assessment were not available. Therefore, the threshold of toxicological concern (TTC) approach was followed to derive the maximum safe feed concentration (EFSA FEEDAP Panel, [2012a](#efs24671-bib-0010){ref-type="ref"}).

All compounds except 5‐methylquinoxaline belong to the Cramer Class II. The calculated safe use level for these compounds is 0.5 mg/kg complete feed for cattle, salmonids and non‐food‐producing animals, and 0.3 mg/kg complete feed for pigs and poultry. 5‐Methylquinoxaline (Cramer Class III) is safe at 0.0 mg/kg complete feed for cattle, salmonids and non‐food‐producing animals, and 0.05 mg/kg complete feed for pigs and poultry.

#### 3.2.3.1. Conclusions on safety for the target species {#efs24671-sec-0017}

The FEEDAP Panel concludes that: 2,3‐diethylpyrazine \[14.005\], 2‐ethyl‐3‐methylpyrazine \[14.006\], 5,6,7,8‐tetrahydroquinoxaline \[14.015\], 2,3,5,6‐tetramethylpyrazine \[14.018\], 2,3,5‐trimethylpyrazine \[14.019\], 2,5‐dimethylpyrazine \[14.020\], 2,6‐dimethylpyrazine \[14.021\], 2‐ethylpyrazine \[14.022\], 2‐ethyl‐3,5‐dimethylpyrazine \[14.024\],2,5 or 6‐methoxy‐3‐methylpyrazine \[14.025\], 2‐methylpyrazine \[14.027\], acetylpyrazine \[14.032\], 6,7‐dihydro‐5‐methyl‐5*H*‐cyclopenta(b)pyrazine \[14.037\], 2‐isobutyl‐3‐methoxypyrazine \[14.043\], 2‐acetyl‐3‐ethylpyrazine \[14.049\], 2,3‐dimethylpyrazine \[14.050\], 2,3‐diethyl‐5‐methylpyrazine \[14.056\], 2‐(*sec*‐butyl)‐3‐methoxypyrazine \[14.062\], 3,(5‐ or 6‐)‐dimethyl‐2‐ethylpyrazine \[14.100\], 2‐ethyl‐3‐methoxypyrazine \[14.112\] and 2‐methoxy‐3‐methylpyrazine \[14.126\] are safe at the proposed maximum dose level (0.5 mg/kg complete feed) for cattle, salmonids and non‐food‐producing animals, and at the proposed normal use level of 0.1 mg/kg complete feed for pigs and poultry;5‐methylquinoxaline \[14.028\] is safe only at concentrations below the proposed use levels (0.08 mg/kg complete feed for cattle, salmonids and non‐food‐producing animals, and 0.05 mg/kg complete feed for pigs and poultry).

### 3.2.4. Safety for the consumer {#efs24671-sec-0018}

The safety for the consumer of the compounds in CG 24, used as food flavours, has already been assessed by JECFA (WHO, [2002a](#efs24671-bib-0033){ref-type="ref"},[b](#efs24671-bib-0034){ref-type="ref"}) and EFSA (EFSA [2008a](#efs24671-bib-0006){ref-type="ref"}, EFSA CEF Panel, [2011a](#efs24671-bib-0008){ref-type="ref"}). All these compounds are presently authorised as food flavourings without limitations.[5](#efs24671-note-1009){ref-type="fn"}

Given the proposed use levels of CG 24 compounds to be applied in feed, the expected metabolism and excretion in target animals (see Section [3.2.1](#efs24671-sec-0014){ref-type="sec"}), the FEEDAP Panel considers that the possible residues in food derived from animals fed with these flavourings would not appreciably increase the human intake levels of these compounds. Consequently, no safety concern would arise for the consumer from the use of these 22 compounds up to the highest safe level in feeds.

### 3.2.5. Safety for the user {#efs24671-sec-0019}

No specific data on the safety for the user were provided. In the material safety data sheets,[11](#efs24671-note-1015){ref-type="fn"} hazards for skin and eye contact and respiratory exposure are recognised for the majority of the compounds under application. Most are classified as irritating to the respiratory system.

### 3.2.6. Safety for the environment {#efs24671-sec-0020}

The additions of naturally occurring substances that will not result in a substantial increase in the concentration in the environment are exempt from further assessment. Examination of the published literature shows that this applies to 14 substances, namely 2‐ethyl‐3‐methylpyrazine \[14.006\], 2,3,5,6‐tetramethylpyrazine \[14.018\], 2,3,5‐trimethylpyrazine \[14.019\], 2,5‐dimethylpyrazine \[14.020\], 2,6‐dimethylpyrazine \[14.021\], 2‐ethylpyrazine \[14.022\], 2‐ethyl‐3,5‐dimethylpyrazine \[14.024\], 2,5 or 6‐methoxy‐3‐methylpyrazine \[14.025\], 2‐methylpyrazine \[14.027\], acetylpyrazine \[14.032\], 6,7‐dihydro‐5‐methyl‐5*H*‐cyclopenta(b)pyrazine \[14.037\], 2‐isobutyl‐3‐methoxypyrazine \[14.043\], 2,3‐dimethylpyrazine \[14.050\] and 3,(5‐ or 6‐)‐dimethyl‐2‐ethylpyrazine \[14.100\], which occur in the environment at levels above the application rate of 0.5 mg/kg feed (data taken from the Netherlands Organisation for Applied Scientific Research (TNO) database Volatile Compounds in Food *ver*. 14.1; Burdock, 2003).[12](#efs24671-note-1016){ref-type="fn"}

The other eight compounds, namely 2,3‐diethylpyrazine \[14.005\], 5,6,7,8‐tetrahydroquinoxaline \[14.015\], 5‐methylquinoxaline \[14.028\], 2‐acetyl‐3‐ethylpyrazine \[14.049\], 2,3‐diethyl‐5‐methylpyrazine \[14.056\], 2‐(*sec*‐butyl)‐3‐methoxypyrazine \[14.062\], 2‐ethyl‐3‐methoxypyrazine \[14.112\] and 2‐methoxy‐3‐methylpyrazine \[14.126\], could not be shown to occur in the environment at levels above the application rate of 0.5 mg/kg feed. For these compounds, the predicted environmental concentration for soil (PEC~soil~) was calculated based on the use rate (Table [4](#efs24671-tbl-0004){ref-type="table"}) and compared with the trigger values for compartments set in the phase I of the EFSA guidance on environmental risk assessment for feed additives (EFSA, [2008b](#efs24671-bib-0007){ref-type="ref"}).

###### 

Predicted environmental concentration (PEC) values of the eight flavourings of CG 24 under assessment (calculated for lamb manure)

  EU Register name                    CAS No       Dose mg/kg   PEC~soil~ (μg/kg)   PEC~porewater~ (μg/L)   PEC~surfacewater~ (μg/L)
  ----------------------------------- ------------ ------------ ------------------- ----------------------- --------------------------
  2,3‐Diethylpyrazine                 15707‐24‐1   0.5          10.7                15.5                    5.2
  5,6,7,8‐Tetrahydroquinoxaline       34413‐35‐9   0.5          10.7                1.5                     0.5
  5‐Methylquinoxaline                 13708‐12‐8   0.5          10.7                5.2                     1.7
  2‐Acetyl‐3‐ethylpyrazine            32974‐92‐8   0.5          10.7                12.7                    4.2
  2,3‐Diethyl‐5‐methylpyrazine        18138‐04‐0   0.5          10.7                6.3                     2.1
  2‐(*sec*‐Butyl)‐3‐methoxypyrazine   24168‐70‐5   0.5          10.7                2.7                     0.9
  2‐Ethyl‐3‐methoxypyrazine           25680‐58‐4   0.5          10.7                8.7                     2.9
  2‐Methoxy‐3‐methylpyrazine          2847‐30‐5    0.5          10.7                25.1                    8.4

EU: European Union; CAS No: Chemical Abstracts Service number; PEC: predicted environmental concentration.

John Wiley & Sons, Ltd

The PEC~soil~ values are above the threshold of 10 μg/kg (EFSA, [2008b](#efs24671-bib-0007){ref-type="ref"}). The PEC for pore water (PEC~porewater~) is dependent on the sorption, which is different for each compound. For these calculations, the substance‐dependent constants organic carbon sorption constant (*K* ~oc~), molecular weight, vapour pressure and solubility are needed. These were estimated from the Simplified Molecular Input Line Entry Specification (SMILES) notation of the chemical structure using EPIWEB 4.1 (Table [5](#efs24671-tbl-0005){ref-type="table"}).[13](#efs24671-note-1017){ref-type="fn"} This program was also used to derive the SMILES notation from the CAS numbers. The *K* ~oc~ value derived from the first‐order molecular connectivity index was used, as recommended by the EPIWEB program.

###### 

Physicochemical properties predicted by EPIWEB 4.1 for the eight flavourings of CG 24 under assessment

  EU Register name                    CAS No.      Predicted by EPIWEB 4.1                             
  ----------------------------------- ------------ ------------------------- -------- ------- -------- ------
  2,3‐Diethylpyrazine                 15707‐24‐1   15                        136.20   103.0   4,458    32.4
  5,6,7,8‐Tetrahydroquinoxaline       34413‐35‐9   15                        134.20   12.4    2,091    391
  5‐Methylquinoxaline                 13708‐12‐8   13                        144.18   0.7     1,456    110
  2‐Acetyl‐3‐ethylpyrazine            32974‐92‐8   14                        150.18   2.2     20,720   41
  2,3‐Diethyl‐5‐methylpyrazine        18138‐04‐0   20                        150.23   73.1    1,636    89
  2‐(*sec*‐Butyl)‐3‐methoxypyrazine   24168‐70‐5   17                        166.22   4.7     230      220
  2‐Ethyl‐3‐methoxypyrazine           25680‐58‐4   15                        138.17   23.2    2,474    63
  2‐Methoxy‐3‐methylpyrazine          2847‐30‐5    14                        124.14   77.9    8,457    17

EU: European Union; CAS No: Chemical Abstracts Service number.

DT~50~, half‐life of the additive (EPIWB 4.1.BioWin4.1).

*K* ~oc~, organic carbon sorption constant (EPIWB 4.1.KocWin2.0).

John Wiley & Sons, Ltd

The half‐life (DT~50~) was calculated using BioWin4.1 (Ultimate Survey Model), which gives a rating number. This rating number *r* was translated into a half‐life using the formula by Arnot et al. ([2005](#efs24671-bib-0001){ref-type="ref"}):$$\text{DT}_{50} = 10^{( - r \times 1.07 + 4.12)}$$

This is the general regression used to derive estimates of aerobic environmental biodegradation half‐lives from BioWin4.1 model output.

For the eight substances, the calculated predicted concentrations for groundwater (PECporewater) are above 0.1 μg/L and for soil (PEC~soil~) above 10 μg/kg (Table [4](#efs24671-tbl-0004){ref-type="table"}). Therefore, they are subject to phase II risk assessment.

In the absence of experimental data, the phase II risk assessment was performed using ECOSAR v1.11, which estimates the half‐maximal effective concentration (EC~50~) or lethal concentration (LC~50~) for earthworms, fish, green algae and daphnids from the SMILES notation of the substance. The predicted no effect concentration (PNEC) for terrestrial environment (PNEC~soil~) was determined by dividing the LC~50~ earthworm by an uncertainty factor (UF) of 1,000. The corresponding PNEC for aquatic compartment (PNEC~aquatic~) was derived from the lowest toxicity value for freshwater environment by applying an UF of 1,000.

###### 

Phase II environmental risk assessment of soil and aquatic compartments for CG 24 compounds used as feed additives for terrestrial farm animals (exposure and effect data were modelled using EPIWEB 4.1 and ECOSAR 1.11)

+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| **EU Register name**              | **LC** ~**50**~ [a](#efs24671-note-0024){ref-type="fn"} **Earthworm (mg/kg)** | **PNEC** ~**soil**~ **(μg/kg)** | **PEC** ~**soil**~ **(μg/kg)**                          | **PEC** ~**soil**~ **/PNEC** ~**soil**~ |                                                                     |                                     |
|                                   |                                                                               |                                 |                                                         |                                         |                                                                     |                                     |
| **Soil**                          |                                                                               |                                 |                                                         |                                         |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2,3‐Diethylpyrazine               | 236                                                                           | 236                             | 10.7                                                    | 0.05                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 5,6,7,8‐Tetrahydroquinoxaline     | 238                                                                           | 238                             | 10.7                                                    | 0.04                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 5‐Methylquinoxaline               | 272                                                                           | 272                             | 10.7                                                    | 0.04                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐Acetyl‐3‐ethylpyrazine          | 360                                                                           | 360                             | 10.7                                                    | 0.03                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2,3‐Diethyl‐5‐methylpyrazine      | 228                                                                           | 228                             | 10.7                                                    | 0.05                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐(*sec*‐Butyl)‐3‐methoxypyrazine | 235                                                                           | 235                             | 10.7                                                    | 0.05                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐Ethyl‐3‐methoxypyrazine         | 243                                                                           | 243                             | 10.7                                                    | 0.04                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐Methoxy‐3‐methylpyrazine        | 245                                                                           | 245                             | 10.7                                                    | 0.04                                    |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| **Aquatic**                       | **LC** ~**50**~                                                               | **LC** ~**50**~                 | **EC** ~**50**~ [b](#efs24671-note-0025){ref-type="fn"} | **PNEC** ~**aquatic**~ **(μg/L)**       | **PEC** ~**sw**~ [c](#efs24671-note-0026){ref-type="fn"} **(μg/L)** | **PEC** ~**sw**~ **/PNEC** ~**sw**~ |
|                                   |                                                                               |                                 |                                                         |                                         |                                                                     |                                     |
|                                   | **Fish (mg/L)**                                                               | **Daphnids (mg/L)**             | **Algae (mg/L)**                                        |                                         |                                                                     |                                     |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2,3‐Diethylpyrazine               | 108                                                                           | 61                              | 46                                                      | 46                                      | 5.2                                                                 | 0.11                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 5,6,7,8‐Tetrahydroquinoxaline     | 134                                                                           | 75                              | 54                                                      | 54                                      | 0.5                                                                 | 0.01                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 5‐Methylquinoxaline               | 238                                                                           | 131                             | 86                                                      | 86                                      | 1.7                                                                 | 0.02                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐Acetyl‐3‐ethylpyrazine          | 1,974                                                                         | 990                             | 442                                                     | 442                                     | 4.2                                                                 | 0.01                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2,3‐Diethyl‐5‐methylpyrazine      | 38                                                                            | 23                              | 21                                                      | 21                                      | 2.1                                                                 | 0.10                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐(sec‐Butyl)‐3‐methoxypyrazine   | 23                                                                            | 14                              | 15                                                      | 14                                      | 0.9                                                                 | 0.06                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐Ethyl‐3‐methoxypyrazine         | 125                                                                           | 70                              | 52                                                      | 52                                      | 2.9                                                                 | 0.06                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+
| 2‐Methoxy‐3‐methylpyrazine        | 309                                                                           | 167                             | 101                                                     | 101                                     | 8.4                                                                 | 0.08                                |
+-----------------------------------+-------------------------------------------------------------------------------+---------------------------------+---------------------------------------------------------+-----------------------------------------+---------------------------------------------------------------------+-------------------------------------+

EU: European Union; PNEC~soil~: predicted no effect concentration for terrestrial environment; PEC~soil~: predicted environmental concentration for soil; PNEC~aquatic~: predicted no effect concentration for aquatic compartment.

LC~50~: the concentration of a test substance which results in a 50% mortality of the test species.

EC~50~: the concentration of a test substance which results in 50% of the test animals being adversely affected (i.e. both mortality and sublethal effects).

PEC~sw~: Predicted environmental concentration in surface water.

John Wiley & Sons, Ltd

For all eight compounds, the ratio PEC/PNEC for soil and surface water was \< 1 (Table [6](#efs24671-tbl-0006){ref-type="table"}), indicating that there is no risk for the terrestrial and fresh water compartments at the maximum proposed use level of 0.5 mg/kg.

If used in fish feed at the highest proposed use level of 0.5 mg/kg complete feed in land‐based aquaculture systems, none of all additives under assessment would result in a predicted environmental concentration of the additive (parent compound) in surface water (PEC~swaq~) above the trigger value of 0.1 μg/L when calculated according to the guidance (EFSA, [2008b](#efs24671-bib-0007){ref-type="ref"}). For sea cages, a dietary concentration of 0.047 mg/kg would ensure that the threshold for the predicted environmental concentration of the additive (parent compound) in sediment (PEC~sed~) of 10 μg/kg is not exceeded when calculated according to the EFSA guidance (EFSA, [2008b](#efs24671-bib-0007){ref-type="ref"}).

#### 3.2.6.1. Conclusions on safety for the environment {#efs24671-sec-0021}

The maximum proposed use level of 0.5 mg/kg is unlikely to have detrimental effects on the terrestrial and fresh water compartments for any of the compounds under application. For the marine environment, the safe use level is estimated to be 0.05 mg/kg feed.

3.3. Efficacy {#efs24671-sec-0022}
-------------

Since all 22 compounds are used in food as flavourings, and their function in feed is essentially the same as that in food no further demonstration of efficacy is necessary.

4. Conclusions {#efs24671-sec-0023}
==============

The FEEDAP Panel concludes that 2,3‐diethylpyrazine \[14.005\], 2‐ethyl‐3‐methylpyrazine \[14.006\], 5,6,7,8‐tetrahydroquinoxaline \[14.015\], 2,3,5,6‐tetramethylpyrazine \[14.018\], 2,3,5‐trimethylpyrazine \[14.019\], 2,5‐dimethylpyrazine \[14.020\], 2,6‐dimethylpyrazine \[14.021\], 2‐ethylpyrazine \[14.022\], 2‐ethyl‐3,5‐dimethylpyrazine \[14.024\], 2,5 or 6‐methoxy‐3‐methylpyrazine \[14.025\], 2‐methylpyrazine \[14.027\], acetylpyrazine \[14.032\], 6,7‐dihydro‐5‐methyl‐5*H*‐cyclopenta(b)pyrazine \[14.037\], 2‐isobutyl‐3‐methoxypyrazine \[14.043\], 2‐acetyl‐3‐ethylpyrazine \[14.049\], 2,3‐dimethylpyrazine \[14.050\], 2,3‐diethyl‐5‐methylpyrazine \[14.056\], 2‐(*sec*‐butyl)‐3‐methoxypyrazine \[14.062\], 3,(5‐ or 6‐)‐dimethyl‐2‐ethylpyrazine \[14.100\], 2‐ethyl‐3‐methoxypyrazine \[14.112\] and 2‐methoxy‐3‐methylpyrazine \[14.126\] are safe at the proposed maximum dose level (0.5 mg/kg complete feed) as feed for cattle, salmonids and non‐food‐producing animals, and at the proposed normal use level of 0.1 mg/kg complete feed for pigs and poultry; 5‐methylquinoxaline \[14.028\] is safe only at concentrations below the proposed use levels (0.08 mg/kg complete feed for cattle, salmonids and non‐food‐producing animals, and 0.05 mg/kg complete feed for pigs and poultry).

No safety concern would arise for the consumer from the use of these compounds up to the highest proposed level in feeds.

Hazards for skin and eye contact and respiratory exposure are recognised for the majority of the compounds under application. Most are classified as irritating to the respiratory system.

The maximum proposed use level of 0.5 mg/kg is unlikely to have detrimental effects on the terrestrial and fresh water compartments for any of the compounds under application.

Because all the compounds under assessment are used in food as flavourings and their function in feed is essentially the same as that in food, no further demonstration of efficacy is necessary.

Documentation provided to EFSA {#efs24671-sec-0024}
==============================

Chemically defined flavourings from Flavouring Group 24 -- Pyrazine derivatives for all animal species and categories. July 2010. Submitted by Feed Flavourings Authorisation Consortium European Economic Interest Grouping (FFAC EEIG).Chemically defined flavourings from Flavouring Group 24 -- Pyrazine derivatives for all animal species and categories. Supplementary information. June 2011. Submitted by Feed Flavourings Authorisation Consortium European Economic Interest Grouping (FFAC EEIG).Chemically defined flavourings from Flavouring Group 24 -- Pyrazine derivatives for all animal species and categories. Supplementary information. January 2012. Submitted by Feed Flavourings Authorisation Consortium European Economic Interest Grouping (FFAC EEIG).Chemically defined flavourings from Flavouring Group 24 -- Pyrazine derivatives for all animal species and categories. Supplementary information. September 2016. Submitted by Feed Flavourings Authorisation Consortium European Economic Interest Grouping (FFAC EEIG).Evaluation report of the European Union Reference Laboratory for Feed Additives on the methods(s) of analysis for Chemically Defined Flavourings -- from Chemical Group 24 -- Pyrazine derivatives.Comments from the Member States.

Abbreviations {#efs24671-sec-0025}
=============

ADIacceptable daily intakeADMEabsorption, distribution, metabolism and excretionbwbody weightCASChemical Abstracts ServiceCDCommission DecisionCDGchemically defined groupCEFEFSA Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing AidsCGchemical groupDMdry matterDT~50~degradation half‐timeEC~50~half‐maximal effective concentrationECOSARcomponent program of EPI suite™EEIGEuropean Economic Interest GroupingEPI suiteEstimation Programs Interface (EPI) Suite™EURLEuropean Union Reference LaboratoryFAOFood and Agriculture OrganizationFEEDAPEFSA Scientific Panel on Additives and Products or Substances used in Animal FeedFFACFeed Flavourings authorisation Consortium of (FEFANA) the EU Association of Specialty Feed Ingredients and their MixturesFGEFlavouring Group EvaluationFLAVISthe EU Flavour Information SystemFL‐NoFLAVIS numberGC--MSgas chromatography--mass spectrometryJECFAThe Joint FAO/WHO Expert Committee on Food Additives*K*~*oc*~organic carbon sorption constant*K*~*ow*~octanol--water partition coefficientLC~50~lethal concentration 50Log K~ow~logarithm of octanol--water partition coefficientNOAELno observed adverse effect levelPECpredicted environmental concentrationPEC~sed~predicted environmental concentration of the additive (parent compound) in sedimentPEC~porewater~predicted environmental concentration for porewaterPEC~soil~predicted environmental concentration for soilPEC~surfacewater~predicted environmental concentration for surface waterPEC~swaq~predicted environmental concentration of the additive (parent compound) in surface waterPNECpredicted no environmental concentrationPNEC~soil~predicted no environmental concentration for terrestrial environmentPNEC~aquatic~predicted no environmental concentration for aquatic compartmentRTLretention time lockingSMILESSimplified Molecular Input Line Entry SpecificationTNONetherlands Organisation for Applied Scientific ResearchTTCthreshold of toxicological concernUFuncertainty factorWHOWorld Health Organization

Annex A -- Executive Summary of the Evaluation Report of the European Union Reference Laboratory for Feed Additives on the Method(s) of Analysis for Chemically defined flavourings from Chemical group 24 -- Pyrazine derivatives {#efs24671-sec-0026}
==================================================================================================================================================================================================================================

The *Chemically Defined Flavourings ‐ Group 24* (*Pyrazine derivatives*), in this application comprises 22 substances, for which authorisation as feed additives is sought under the category "sensory additives", functional group 2(b) "flavouring compounds", according to the classification system of Annex I of Regulation (EC) No 1831/2003.

In the current application submitted according to Article 4(1) and Article 10 (2) of Regulation (EC) No 1831/2003, the authorisation for all species and categories is requested. The flavouring compounds of interest have a purity ranging from 95% to 99%.

*Mixtures of flavouring compounds* are intended to be incorporated only into *feedingstuffs* or drinking *water*. The Applicant suggested no minimum or maximum levels for the different flavouring compounds in *feedingstuffs*.

For the identification of volatile chemically defined flavouring compounds *CDG24* in the *feed additive,* the Applicant submitted a qualitative multi‐analyte gas‐chromatography mass‐spectrometry (GC‐MS) method, using Retention Time Locking (RTL), which allows a close match of retention times on GC‐MS. By making an adjustment to the inlet pressure, the retention times can be closely matched to those of a reference chromatogram. It is then possible to screen samples for the presence of target compounds using a mass spectral database of RTL spectra. The Applicant maintained two FLAVOR2 databases/libraries (for retention times and for MS spectra) containing data for more than 409 flavouring compounds. These libraries were provided to the CRL. The Applicant provided the typical chromatogram for the *CDG24* of interest.

In order to demonstrate the transferability of the proposed analytical method (relevant for the method verification), the Applicant prepared a model mixture of flavouring compounds on a solid carrier to be identified by two independent expert laboratories. This mixture contained twenty chemically defined flavourings belonging to twenty different chemical groups to represent the whole spectrum of compounds in use as feed flavourings with respect to their volatility and polarity. Both laboratories properly identified all the flavouring compounds in all the formulations. Since the substances of *CDG24* are within the volatility and polarity range of the model mixture tested, the Applicant concluded that the proposed analytical method is suitable to determine qualitatively the presence of the substances from *CDG24* in the *mixture of flavouring compounds*.

Based on the satisfactory experimental evidence provided, the CRL recommends for official control for the qualitative identification in the *feed additive* of the individual (or mixture of) *flavouring compounds* of interest the GC‐MS‐RTL (Agilent specific) method submitted by the Applicant.
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